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A 13-year-old girl presented to the ophthalmology 
clinic complaining of painless decrease in vision 
in both eyes from two weeks before presentation. 
Visual loss had been accompanied by fever, 
muscle pain, chills and headache; however the 
patient had become afebrile four days before 
referral.
Ocular examination revealed best corrected 
visual acuity (BCVA) of counting fingers in 
the right eye (OD) and 3/200 in her left eye 
(OS). The anterior segment was normal in both 
eyes. Fundus examination revealed multiple 
superficial retinal hemorrhages, Roth spots, 
and large subhyaloid hemorrhages in both 
eyes (Figures 1 and 2). 
The patient was referred to an internist for 
systemic evaluation which disclosed multiple 
petechial hemorrhages on her extremities. 
Blood counts showed leukopenia (3,200 cells/
ml), thrombocytopenia (22,000 cells/ml) and 
hemoglobin level of 11 g/dL. IgM for Dengue 
by enzyme-linked immunosorbent assay was 
positive confirming a diagnosis of Dengue 
hemorrhagic fever (One step rapid card test, 
SD BIOLINE Dengue Duo, Dengue NS1 Ag 
+ Ab Combo kit, Standard Diagnostic Inc., 
Kyonggi-Do, South Korea). 
The patient was treated with packed cell/
platelet transfusions and re-examined after 3 
weeks. BCVA had slightly improved to 20/200 
OD (Figure 3) and 6/200 OS. As she was still 
medically unstable, a choice of observation 
or Nd:YAG laser hyaloidotomy was offered. 
Nd:YAG hyaloidotomy was performed on the 
left eye with the following specifications: spot 
size, 50 to 100 μm; power, 300 mW to 500 mW; 
and duration, 100 ms to 300 ms. Two bursts were 
applied and hyaloidotomy was performed on 
the stretched posterior hyaloid surface (Fig. 4). 
The patient was revisited after 1 week. BCVA at 
this time interval was 20/400 OD and 20/30 OS 
(the treated eye). At final follow-up, 3 months 
after initial presentation, the patient had stable 
visual acuity (Figures 5 and 6).
Figure 2.  Color  fundus  photograph  of  the  left  eye 
showing  Roth  spots  (small  arrow),  border  of  the 
posterior hyaloid (arrowhead), and a large subhyaloid 
hemorrhage (large arrow).
Figure 1.  Color  fundus  photograph  of  the  right  eye 
with  Roth  spots  (arrowhead)  and  a  large  subhyaloid 
hemorrhage (arrow).Photo Essay; Dhasmana
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DISCUSSION
Dengue is caused by a flavivirus transmitted 
by a mosquito, Aedes aegypti.1 The disease has 
a wide spectrum of presentations. Symptoms 
range from mild fever to high incapacitating 
fever with severe headache, pain behind the 
eyes, muscle and joint pain, and rash. Dengue 
hemorrhagic fever (DHF) is a potentially lethal 
complication, mainly affecting children. DHF 
is defined by the World Health Organization 
(WHO) as dengue fever associated with 
thrombocytopenia (less than 100,000 cells/
mm3) and hemoconcentration (hematocrit 20% 
above baseline). WHO estimates two fifths 
of the world’s population, are now at risk of 
dengue and that there may be 50 million cases 
of dengue infection worldwide every year.2 
The clinical features of dengue fever vary 
according to the age of the patient. Infants and 
young children may develop fever with rash. 
Older children and adults may have either 
mild fever or classic incapacitating disease 
with abrupt onset and high fever, severe 
headache, pain behind the eyes, muscle and 
joint pain, and rash. Ocular symptoms have 
been described in 30% of cases.3 Common 
ophthalmic signs reported in various studies 
include scattered blot and flame-shaped macular 
hemorrhages, macular edema, retinal vasculitis, 
intermediate uveitis, posterior vitreous cells, 
and subconjunctival hemorrhage.3-5 Other less 
Figure 4. Fundus photograph of the left eye immediately 
after hyaloidotomy (arrow shows trickling of blood from 
the punctured hyaloid).
Figure 3.  Fundus  photograph  of  the  right  eye  after  3 
weeks of observation.
Figure 6.  Color  fundus  photograph  of  the  left  eye  3 
months after initial presentation (arrow shows internal 
limiting membrane wrinkling with pigmentary changes).
Figure 5.  Color  fundus  photograph  of  the  right  eye  3 
months after initial presentation showing residual pre-
macular hemorrhage.Photo Essay; Dhasmana
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common findings include anterior uveitis and 
inflammatory optic neuropathy.6,7
The pathogenesis of ocular complications of 
dengue fever is yet unknown. Thrombocytopenia 
in severe dengue may predispose to hemorrhage. 
The development of retinal hemorrhage implies 
local injury to retinal vessels, the cause of 
which remains unknown. On the other hand, 
increased vascular permeability in response to 
immune-mediated cytokine release (capillary 
leak syndrome) is known to occur in DHF.8
Premacular subhyaloid hemorrhage is 
rare in children. It may occur due to trauma, 
hematological disorders such as leukemia, 
after retinal vascular rupture associated with 
physical exertion (Valsalva retinopathy), or 
shaken baby syndrome.9
Spontaneous resorption of subhyaloid 
hemorrhage may occur, but may result in 
permanent visual impairment due to pigmentary 
macular changes. Contact with hemoglobin 
and iron over a prolonged period may result 
in formation of epiretinal membranes and toxic 
damage to the retina. Different techniques 
have been described for the management of 
premacular hemorrhage. These include pars 
plana vitrectomy, pneumatic displacement of 
hemorrhage by intravitreal injection of gas and 
use of tissue plasminogen activator. Nd:YAG 
or argon laser posterior hyaloidotomy is an 
alternative for releasing the subhyaloid blood 
into the vitreous cavity thereby facilitating 
resorption of the blood cells.10,11
Dengue is a very rare cause of bilateral 
subhyaloid hemorrhage. There is only one 
report on bilateral vitreous hemorrhage in 
the literature.12 In our case, as the patient was 
medically unstable, Nd:YAG hyaloidotomy 
seemed to be the most appropriate treatment 
modality; this helped the patient regain 
ambulatory vision much earlier in her treated 
eye as compared to the fellow eye.
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